Recurrence-free survival after curative resection of non-small cell lung cancer between inhalational gas anesthesia and propofol-based total intravenous anesthesia: a multicenter, randomized, clinical trial (GAS TIVA trial): protocol description

Recurrence-free survival after curative resection of non-small cell lung cancer between inhalational gas anesthesia and propofol-based total intravenous anesthesia: a multicenter, randomized, clinical trial (GAS TIVA trial): protocol description

Abstract Background Surgery is the primary treatment for non-small cell lung cancer (NSCLC), but microscopic residual disease may be unavoidable. Preclinical studies have shown that volatile anesthetics might suppress host immunity and promote a pro-malignant environment that supports cancer cell pr...

Full description

Bibliographic Details
Main Authors: Jeayoun Kim, Susie Yoon, In-Kyung Song, Kyuho Lee, Wonjung Hwang, Heezoo Kim, Dong Kyu Lee, Hyun Kyoung Lim, Seong-Hyop Kim, Jong Wha Lee, Boohwi Hong, Randal S. Blank, Alessia Pedoto, Wanda Popescu, Glezinis Theresa, Archer Kilbourne Martin, Mathew Patteril, Atipong Pathanasethpong, Yada Thongsuk, Tanatporn Pisitpitayasaree, Aijie Huang, Hui Yu, Poonam Malhotra Kapoor, Kyunga Kim, Sang Ah Chi, Hyun Joo Ahn
Format: Article
Language:English
Published: BMC 2024-07-01
Series:Perioperative Medicine
Subjects:
Anesthesia
Desflurane
Inhalational anesthesia
Isoflurane, Lung Neoplasm
Metastasis
Non-small cell lung cancer
Online Access:https://doi.org/10.1186/s13741-024-00436-1

Internet

https://doi.org/10.1186/s13741-024-00436-1

Similar Items